Marlene Estefania Campos-Morales
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marlene Estefania Campos-Morales has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jesús Campos-García
Laboratorio de Biotecnología Microbiana, Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, México
3 shared publications - Laura Hernández-Padilla
Instituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58000, Michoacán, Mexico
3 shared publications - Lorena Martínez-Alcantar
Instituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58000, Michoacán, Mexico
3 shared publications - Mayra Xochitl Durán-Maldonado
Laboratorio de Biotecnología Microbiana, Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Mexico
3 shared publications - Ximena Hernandez-Ramos
Instituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58030, Michoacán, Mexico
2 shared publications - Alma Laura Díaz-Pérez
Laboratorio de Biotecnología Microbiana, Instituto de Investigaciones Químico-Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58030, Mich, Mexico
1 shared publication
Latest Publications
- Open Access
Bacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model
Triple-negative breast cancer (TNBC) is a highly aggressive subtype linked to a high rate of metastasis and low survival rates worldwide. Bacterial cyclodipeptides (CDPs) demonstrate anticancer properties by targeting multiple signaling pathways. The impact of CDPs on TNBC metastasis was evaluated both in vitro and in advanced-stage tumors in immunosuppressed female mice. CDPs significantly decreased the migratory and invasive capabilities of the MDA-MB-231 cell line, outperforming methotrexate (MTX). This effect was associated with the inhibition of Akt/mTOR/S6K phosphorylation, as well as Gab1, Vimentin, and FOXO1. Mice bearing MDA-MB-231 xenografts treated with CDPs alone or in combination with MTX showed near-complete suppression of primary tumors and metastatic sites in organs; notably, the combined treatment displayed a synergistic effect. Consequently, key proteins involved in tumor progression and metastasis, including p-Akt, p-Gab1, and FOXO1, were markedly inhibited in tumors from CDP-treated mice. Additionally, genes related to EMT, invasiveness, and immune modulation—including PTEN, SNAIL, CXCL1, BRCA1, GADD45A, and PD-L1—were dysregulated in the livers of TNBC-bearing mice; however, CDP treatment restored their expression more effectively than MTX. These findings suggest that the anti-metastatic effects of CDPs in the TNBC xenograft model involve modulation of the Akt/mTOR/S6K pathway, EMT, invasiveness, and immune modulation, highlighting their potential for further preclinical development.
Open AccessBacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model
Triple-negative breast cancer (TNBC) is a highly aggressive subtype linked to a high rate of metastasis and low survival rates worldwide. Bacterial cyclodipeptides (CDPs) demonstrate anticancer properties by targeting multiple signaling pathways. The impact of CDPs on TNBC metastasis was evaluated both in vitro and in advanced-stage tumors in immunosuppressed female mice. CDPs significantly decreased the migratory and invasive capabilities of the MDA-MB-231 cell line, outperforming methotrexate (MTX). This effect was associated with the inhibition of Akt/mTOR/S6K phosphorylation, as well as Gab1, Vimentin, and FOXO1. Mice bearing MDA-MB-231 xenografts treated with CDPs alone or in combination with MTX showed near-complete suppression of primary tumors and metastatic sites in organs; notably, the combined treatment displayed a synergistic effect. Consequently, key proteins involved in tumor progression and metastasis, including p-Akt, p-Gab1, and FOXO1, were markedly inhibited in tumors from CDP-treated mice. Additionally, genes related to EMT, invasiveness, and immune modulation—including PTEN, SNAIL, CXCL1, BRCA1, GADD45A, and PD-L1—were dysregulated in the livers of TNBC-bearing mice; however, CDP treatment restored their expression more effectively than MTX. These findings suggest that the anti-metastatic effects of CDPs in the TNBC xenograft model involve modulation of the Akt/mTOR/S6K pathway, EMT, invasiveness, and immune modulation, highlighting their potential for further preclinical development.
- Open Access
- 19 January 2026
- Published by MDPI AG in Preprints.org
Bacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype associated with a high metastatic rate and low survival worldwide. Bacterial cyclodipeptides (CDPs) exhibit anticancer properties by targeting multiple signaling pathways. Methods: The effect of CDPs on the metastasis of the TNBC MDA-MB-231 cell line was evaluated both in vitro and in advanced-stage tumors in immunosuppressed female mice. Results: CDPs more effectively reduced the migratory and invasive abilities of the MDA-MB-231 cell line than methotrexate (MTX). The anti-metastatic effect correlated with inhibition of the Akt/mTOR/S6K pathway, evidenced by decreased expression of markers such as Gab1, Vimentin, and FOXO1. Mice with MDA-MB-231 xenografts treated with CDPs, alone or in combination with MTX, showed near-complete suppression of primary tumor growth and metastatic foci in tumor and organ tissues. Key proteins involved in signaling pathways associated with tumor progression and metastasis such as p-Akt, p-Gab1, and FOXO1 were markedly reduced expression in tumor tissues following xenografted mice CDPs treated. Notably, genes involved in EMT, invasiveness, and metastasis—including PTEN, SNAIL, CXCL1, BRCA1, GADD45A, and PD-L1—were dysregulated in the livers of animals with TNBC, but CDPs treatment restored them to healthy levels more effectively than MTX. Conclusions: The anti-metastatic effects of CDPs in the MDA-MB-231 line involve inhibiting phosphorylation of components of the Akt/mTOR/S6K pathway and reducing metastasis markers and proliferation regulators, as demonstrated in cultures of the MDA-MB-231 line and in tumor and liver tissues from the TNBC xenograft mouse model. The anti-metastatic activity of CDPs was more effective than MTX alone; however, combined treatment produced a synergistic effect, increasing efficacy. These findings offer new insights into the mechanism of action of CDPs and their potential as candidates for further preclinical development.
- 19 January 2026
- Published by MDPI AG in Preprints.org
Open AccessBacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype associated with a high metastatic rate and low survival worldwide. Bacterial cyclodipeptides (CDPs) exhibit anticancer properties by targeting multiple signaling pathways. Methods: The effect of CDPs on the metastasis of the TNBC MDA-MB-231 cell line was evaluated both in vitro and in advanced-stage tumors in immunosuppressed female mice. Results: CDPs more effectively reduced the migratory and invasive abilities of the MDA-MB-231 cell line than methotrexate (MTX). The anti-metastatic effect correlated with inhibition of the Akt/mTOR/S6K pathway, evidenced by decreased expression of markers such as Gab1, Vimentin, and FOXO1. Mice with MDA-MB-231 xenografts treated with CDPs, alone or in combination with MTX, showed near-complete suppression of primary tumor growth and metastatic foci in tumor and organ tissues. Key proteins involved in signaling pathways associated with tumor progression and metastasis such as p-Akt, p-Gab1, and FOXO1 were markedly reduced expression in tumor tissues following xenografted mice CDPs treated. Notably, genes involved in EMT, invasiveness, and metastasis—including PTEN, SNAIL, CXCL1, BRCA1, GADD45A, and PD-L1—were dysregulated in the livers of animals with TNBC, but CDPs treatment restored them to healthy levels more effectively than MTX. Conclusions: The anti-metastatic effects of CDPs in the MDA-MB-231 line involve inhibiting phosphorylation of components of the Akt/mTOR/S6K pathway and reducing metastasis markers and proliferation regulators, as demonstrated in cultures of the MDA-MB-231 line and in tumor and liver tissues from the TNBC xenograft mouse model. The anti-metastatic activity of CDPs was more effective than MTX alone; however, combined treatment produced a synergistic effect, increasing efficacy. These findings offer new insights into the mechanism of action of CDPs and their potential as candidates for further preclinical development.
- Open Access
- 12 December 2024
- Published by MDPI AG in Kinases and Phosphatases
- Vol. 2 (4) , 346-378
Cyclic Peptides as Protein Kinase Modulators and Their Involvement in the Treatment of Diverse Human Diseases
Protein kinases (PKs) are an important and very popular family of enzymes that play a vital role in regulating cellular processes via the phosphorylation of targets. Nevertheless, modifications in the expression due to mutations or their dysregulation can lead to diseases, including autoimmune disorders, cardiovascular problems, diabetes, neurological diseases, and cancers. Cyclic ultra-short peptides are amazing structures with unique properties. The cyclicity of cyclic peptides (CPs) can mimic the interactions between PKs and natural substrates, influencing the enzyme activity essential in health and disease physiology. Our review summarized that interference in the signal transduction mechanism of the PKs by CPs implies the inhibition of substrate phosphorylation at the level of the active site, similar to anti-neoplastic drugs. The remarkable capacity of CPs to interact with targets positions them as promising candidates for developing protein kinase inhibitors in treating diseases. This review offers new insights for CPs in molecular mechanisms, cytotoxicity, target selectivity, and the possibility of designing more effective and safe therapeutic agents.
- 12 December 2024
- Published by MDPI AG in Kinases and Phosphatases
- Vol. 2 (4) , 346-378
Open AccessCyclic Peptides as Protein Kinase Modulators and Their Involvement in the Treatment of Diverse Human Diseases
Protein kinases (PKs) are an important and very popular family of enzymes that play a vital role in regulating cellular processes via the phosphorylation of targets. Nevertheless, modifications in the expression due to mutations or their dysregulation can lead to diseases, including autoimmune disorders, cardiovascular problems, diabetes, neurological diseases, and cancers. Cyclic ultra-short peptides are amazing structures with unique properties. The cyclicity of cyclic peptides (CPs) can mimic the interactions between PKs and natural substrates, influencing the enzyme activity essential in health and disease physiology. Our review summarized that interference in the signal transduction mechanism of the PKs by CPs implies the inhibition of substrate phosphorylation at the level of the active site, similar to anti-neoplastic drugs. The remarkable capacity of CPs to interact with targets positions them as promising candidates for developing protein kinase inhibitors in treating diseases. This review offers new insights for CPs in molecular mechanisms, cytotoxicity, target selectivity, and the possibility of designing more effective and safe therapeutic agents.
- Open Access
- 10 December 2024
- Published by Universidad Michoacana de San Nicolas de Hidalgo in Milenaria, Ciencia y arte
- No. 24,p. 15-19
Absorción y descomposición de nutrientes: conociendo el sistema digestivo y la microbiota
Tenemos que comer; nos gusta comer; comer nos hace sentir bien, el impulso del hambre debe satisfacerse todos los días. Los alimentos desempeñan un papel fundamental en nuestra vida cotidiana, no sólo por su sabor y su papel social, sino también por su importancia como fuente de nutrientes esenciales, cada uno con su función específica en el cuerpo. La alimentación abarca cualquier sustancia, ya sea sólida o líquida, ingerida por los seres vivos con el propósito de obtener nutrientes mediante el proceso de digestión y el uso de la maquinaria de los microorganismos de la microbiota. Pero sabemos realmente ¿de qué están hechos los alimentos?, ¿qué pasa con ellos una vez que los consumimos?, ¿cómo es que se transforman dentro de nosotros?, ¿cuál es la función de las bacterias?, ¿cómo participan las bacterias en este proceso?, ¿cuál es la relación de las bacterias con la alimentación?; en este artículo realizaremos un viaje y conoceremos la ruta que siguen los alimentos y su relación con las bacterias de la microbiota intestinal.
- 10 December 2024
- Published by Universidad Michoacana de San Nicolas de Hidalgo in Milenaria, Ciencia y arte
- No. 24,p. 15-19
Open AccessAbsorción y descomposición de nutrientes: conociendo el sistema digestivo y la microbiota
Tenemos que comer; nos gusta comer; comer nos hace sentir bien, el impulso del hambre debe satisfacerse todos los días. Los alimentos desempeñan un papel fundamental en nuestra vida cotidiana, no sólo por su sabor y su papel social, sino también por su importancia como fuente de nutrientes esenciales, cada uno con su función específica en el cuerpo. La alimentación abarca cualquier sustancia, ya sea sólida o líquida, ingerida por los seres vivos con el propósito de obtener nutrientes mediante el proceso de digestión y el uso de la maquinaria de los microorganismos de la microbiota. Pero sabemos realmente ¿de qué están hechos los alimentos?, ¿qué pasa con ellos una vez que los consumimos?, ¿cómo es que se transforman dentro de nosotros?, ¿cuál es la función de las bacterias?, ¿cómo participan las bacterias en este proceso?, ¿cuál es la relación de las bacterias con la alimentación?; en este artículo realizaremos un viaje y conoceremos la ruta que siguen los alimentos y su relación con las bacterias de la microbiota intestinal.